tetradecanoylphorbol acetate has been researched along with tellurium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albeck, A; Albeck, M; Brodsky, M; Galit, R; Longo, DL; Sredni, B; Yosef, S | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and tellurium
Article | Year |
---|---|
The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Topics: Animals; Caspase 1; Caspase Inhibitors; Cells, Cultured; Ethylenes; Female; Gene Expression Regulation; Humans; Interferon-gamma; Interleukin-18; Interleukin-1beta; Keratinocytes; Leukocytes; Lipopolysaccharides; Male; Mice; Nitric Oxide; Protein Processing, Post-Translational; RNA, Messenger; Sepsis; Serpins; Survival Rate; Tellurium; Tetradecanoylphorbol Acetate; Viral Proteins | 2007 |